Home › Compare › TYIDY vs ABBV
TYIDY yields 0.76% · ABBV yields 3.06%● Live data
📍 TYIDY pulled ahead of the other in Year 9
Combined, TYIDY + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TYIDY + ABBV for your $10,000?
Toyota Industries Corporation manufactures and sells automobiles, material handling equipment, textile machinery, and others in Japan and internationally. The company operates through Automobile, Materials Handling Equipment, and Textile Machinery segments. It provides vehicles; gas, gasoline, and diesel engines for automobiles, industrial equipment, turbochargers, and foundry parts; car air-conditioning compressors; car electronics comprising DC-DC converters, rear inverters, direct-cooling devices, DC-AC inverters, and charging systems; and stamping dies consists of automotive and lift truck stamping dies. The company also offers counterbalanced lift trucks, electric reach trucks, skid steer loaders, tow tractors, and electric tow tractors; stationary/fixed type racks, nesting pallets, mobile racks, and automated storage and retrieval systems; automatic guided vehicle systems, high speed rail guided vehicle systems, and automatic guided lift and pallet trucks. In addition, it provides spinning machines consisting of ring spinning and roving frames; weaving machinery; and cotton classing and yarn testing instruments, as well as leases materials handling systems and industrial equipment. Further, the company offers aerial work platforms; in-house transporters; software; and funding, loan, and other financial services. Additionally, it is involved in the operation of sports facility and nursing homes; real estate leasing; trucking, warehousing, distribution consulting; building management, construction, and real estate; travel agency, renovation, sale of tube amplifiers, and organizing and running of events; personnel placement, contract office staffing, and patent investigation; management and operation of employee clubs and restaurant management; administrative processing for payroll accounting; and contract manufacturing of electronic devices, as well as sale of hardware. The company was incorporated in 1926 and is headquartered in Kariya, Japan.
Full TYIDY Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.